scispace - formally typeset
K

Kelly J. Hunt

Researcher at Medical University of South Carolina

Publications -  183
Citations -  9691

Kelly J. Hunt is an academic researcher from Medical University of South Carolina. The author has contributed to research in topics: Population & Diabetes mellitus. The author has an hindex of 42, co-authored 158 publications receiving 8596 citations. Previous affiliations of Kelly J. Hunt include University of Texas Health Science Center at San Antonio & United States Department of Veterans Affairs.

Papers
More filters
Journal ArticleDOI

Does the Metabolic Syndrome Improve Identification of Individuals at Risk of Type 2 Diabetes and/or Cardiovascular Disease?

TL;DR: The metabolic syndrome is inferior to established predicting models for either type 2 diabetes or CVD and combined with either predicting model did not improve the prediction of either end point.
Journal ArticleDOI

National Cholesterol Education Program Versus World Health Organization Metabolic Syndrome in Relation to All-Cause and Cardiovascular Mortality in the San Antonio Heart Study

TL;DR: Although both definitions were predictive in the general population, the simpler NCEP definition tended to be more predictive in lower-risk subjects.
Journal ArticleDOI

The National Cholesterol Education Program–Adult Treatment Panel III, International Diabetes Federation, and World Health Organization Definitions of the Metabolic Syndrome as Predictors of Incident Cardiovascular Disease and Diabetes

TL;DR: In this article, the authors examined cardiovascular disease and diabetes risk prediction by the National Cholesterol Education Program (NCEP)-Adult Treatment Panel III (ATPIII), International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome.
Journal ArticleDOI

Fueling the obesity epidemic? Artificially sweetened beverage use and long-term weight gain.

TL;DR: The question whether AS use might be fueling—rather than fighting—the authors' escalating obesity epidemic is raised, as a significant positive dose‐response relationship emerged between baseline ASB consumption and all outcome measures, adjusted for baseline BMI and demographic/behavioral characteristics.